The use of generative artificial intelligence (AI) in clinical trial recruitment is rapidly changing how participants are identified, engaged, and enrolled. While the technology promises efficiency and broader reach, it also raises urgent ethical concerns. First, algorithmic bias in recruitment systems may reproduce or deepen health disparities, threatening efforts to build representative and inclusive clinical studies. Second, reliance on AI-generated patient materials complicates informed consent and transparency, since tailored outputs can obscure critical risks, oversimplify complex medical information, or frame participation in ways that undermine trust. Third, the integration of AI into recruitment workflows necessitates enhanced frameworks for accountability and responsible governance. Unlike traditional recruitment processes, generative AI involves layers of opacity, raising difficult questions about responsibility for errors, bias, and participant harm. Without strong regulatory oversight, the rapid adoption of AI-driven tools risks undermining participant protections and public trust in clinical research.
 
Kalina Kamenova PhD is Founder and Research Director of Canadian Institute For Genomics And Society | Toronto. Her work integrates bioethics, science policy, and public engagement strategies to shape evidence-based decisions in health and biomedical innovation, including genomics, precision medicine, stem cell and regenerative therapies, and artificial intelligence (AI) in healthcare. As Founder and Research Director of the Canadian Institute for Genomics and Society (Genomics4S), I have advanced participatory research, ethical governance, and policy innovation in emerging biotechnologies. Partnering with leading researchers, scientists, policymakers, and industry stakeholders, I have enabled strategic collaboration on initiatives that navigate the ethical and societal dimensions of biomedical innovation. With prior leadership experience at Loyalist College’s Applied Research and Innovation Office and University of Alberta’s Centre for Public Involvement, I have also contributed to fostering cross-sectoral innovation through applied research, policy development, and strategic partnerships. My executive and management expertise spans research administration, grant development, research ethics, team-building, and stakeholder engagement. I am driven by a commitment to responsible research and innovation, ensuring inclusive public discourse around transformative scientific advancements.

Other Posts

A woman in the United Kingdom has become the first in the country to give birth after undergoing a womb transplant from a deceased donor, marking a significant development in reproductive medicine. Unlike most organ [...]

At Mission Hospital, in Asheville, North Carolina, two seven-year-old boys were admitted with a case of measles. However, the cases were not diagnosed right away, and exposed hospital staff and patients to the virus. This [...]

Bioethics is crucial today because it's rooted in the harsh lessons of history, particularly the atrocities committed during World War II, like the Nazi human experiments. The Nuremberg Code was established as a response, emphasizing [...]

There are a growing number of middle class Americans that are selling their plasma, as financial strain threatens their ability to cover basic expenses. Companies frame giving plasma as an altruistic donation, with the compensation [...]

Recent legislation in New York has allowed patients to take lethal medication under conditions, joining 13 other US states with similar policies. After nearly a decade of considering this policy, the final legislation passed attempts [...]

A recent WIRED article, “Inside the New York City Date Night for AI Lovers,” examines a pop-up event where participants engaged in in-person “date nights” with AI companions. Hosted by EVA AI, the event raises [...]